Khara Rahul sold $400K of IRON
Khara Rahul (Chief Legal Officer) sold 5,000 shares of Disc Medicine, Inc. (IRON) at $80.00 ($0.40M total) on 2026-08-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new information is the reported sale size, price, and that it was executed under a pre-arranged 10b5-1 plan. No new guidance, trial result, or corporate action is disclosed.
Market read
Traders may note the insider sale for sentiment, but the 10b5-1 structure and lack of fundamental updates limit trading impact.
What to watch
The article does not state whether the insider’s remaining holdings or other insider activity changed, nor does it provide any company-specific news that would connect the sale to fundamentals.
Background
The article is a SEC Form 4 insider transaction disclosure for Disc Medicine, Inc. (IRON).
Ticker impact
Disc Medicine (IRON) disclosed an insider Form 4 sale by Chief Legal Officer Khara Rahul of 5,000 shares at $80 on 2026-08-06 under a 10b5-1 plan.
Likely limited, short-lived sentiment impact; no clear directional signal beyond typical insider selling.
The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, which generally reduces interpretive weight versus discretionary sales. The article provides no new operational, financial, or regulatory catalyst for IRON.
Market effects
Minimal. Insider 10b5-1 selling in a single biotech name typically does not reset sector expectations.
Minimal.
Minimal.
Counterpoint
A 10b5-1 sale can be purely mechanical and may not reflect bearish views; traders may overreact to the headline framing of “sold.”
Key entities
- issuerDisc Medicine, Inc.
Subject of the Form 4 insider transaction disclosure (IRON).
- insiderKhara Rahul
Chief Legal Officer who sold 5,000 shares under a 10b5-1 plan.